Source link : https://newshealth.biz/health-news/novel-lipogenesis-inhibitor-combo-effective-against-mash/
TOPLINE: The combination of ervogastat plus clesacostat was more effective at resolving metabolic dysfunction-associated steatohepatitis (MASH) without worsening fibrosis in patients with biopsy-confirmed MASH and stage II or III fibrosis than placebo and ervogastat alone; however, the combination was associated with a potentially unfavorable lipid profile that may make it less suitable for patients at […]
The post Novel Lipogenesis Inhibitor Combo Effective Against MASH first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-14 08:53:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8